跳至主要内容
临床试验/NCT03716895
NCT03716895Unknown不适用

Identifying Risk Factors for Complications in Severe Septic Shock

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2018年12月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
1
主要终点
Lactate clearance

研究概览

简要总结

Adults older than 18 years old, admitted to the ICU with a Severe Septic Shock, requiring Norepinephrine at more than 0.25mcg/kg/min, who have signed informed consent form, will be consecutively included, from december 2018 to december 2019.

The primary goal is to look for risk factors associated with an increased in lactate clearance

Secondary goals are the following:

  1. To look for risk factors associated with an increase risk of Hospital and ICU length of stay.
  2. To look for risk factors associated with an increase risk of Acute Kidney Injury.
  3. To look for risk factors associated with a decrease in days alive and free of Mechanical Ventilation, Vasopressors and Renal Replacement Therapy.
  4. To look for risk factors associated with a decrease in Ventilator-free days.
  5. To look for risk factors associated with a decrease in Vasopressor-free days.
  6. To look for risk factors associated with an increase risk of in-hospital mortality.
  7. To look for risk factors associated with an increase risk of Myocardial Infarction and myocardial injury.
  8. To look for risk factors associated with an increase risk of Acute Respiratory Distress Syndrome.
  9. To compare and validate different risk scores in our cohort.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults older than 18 years old admitted to ICU with Severe Septic Shock

排除标准

  • •Rejecting participation by not signing informed consent form.

结局指标

主要结局

Lactate clearance

时间窗: 30 days

Time from hospital arrival to documented serum lactate of less than or equal to 2 mmol/L

次要结局

  • Days alive and free of Mechanical Ventilation, Vasopressors and Renal Replacement Therapy(28 days)
  • Mechanical Ventilation-free days(28 days)
  • Vasopressors-free days(28 days)
  • Rate of Acute Kidney Injury(28 days)
  • ICU length of stay(28 days)
  • Hospital length of stay(30 days)
  • Rate of In-hospital Mortality(30 days)
  • Rate of Acute Respiratory Distress Syndrome(28 days)
  • Rate of New Atrial Fibrilation(28 days)

研究者

发起方
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marc Vives

Clinical Research Lead. Department of Anesthesiology & Critical Care

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

研究点 (1)

Loading locations...

相似试验

Severe Septic Shock Complications | 临床试验